Fibrous dysplasia associated with increased breast cancer risk

September 14, 2017

(HealthDay)—Patients with fibrous dysplasia (FD) are at increased risk for breast cancer, according to a study published online Aug. 30 in the Journal of Bone and Mineral Research.

Bas C.J. Majoor, M.D., from the Leiden University Medical Center in the Netherlands, and colleagues used hospital records from 134 female FD patients in the Netherlands and 121 in the United States to evaluate the potential relationship between and FD.

The researchers found that 15 patients (six polyostotic and nine McCune-Albright syndrome) had cancer (87 percent thoracic localizations). Using the Dutch Pathology Registry, they validated a breast cancer incidence rate of 7.5 percent at a of 46 years (6.5 percent at 51 years). Compared with the Dutch general population, the breast cancer risk in the study participants was increased 3.4-fold; it was increased 13.2-fold in thoracic disease. The breast cancer incidence rate in the U.S. cohort was 4.5 percent at a median age of 36 years. Compared with the U.S. general population, the in study subjects was increased 3.9-fold; it was increased 5.7-fold in thoracic disease. Four breast cancer specimens were positive for the GNAS mutation (44 percent).

"Risk of breast cancer is increased at a younger age, particularly in polyostotic FD, suggesting that screening for breast cancer should be considered in this particular group at a younger age than currently advocated by national guidelines," the authors write.

Explore further: Endometrial ablation doesn't increase cancer risk

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Endometrial ablation doesn't increase cancer risk

August 14, 2017
(HealthDay)—For women in Finland, endometrial ablation is not associated with increased risk of endometrial or breast cancer, according to a study published in the September issue of Obstetrics & Gynecology.

Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

July 20, 2017
Genetic mutations in BRCA1 and BRCA2 increase the risk of breast and ovarian cancer in Ashkenazi Jewish women. A new article published by JAMA Oncology examines the likelihood of carrying another cancer-predisposing mutation ...

IVF treatment not associated with increased risk of breast cancer

July 19, 2016
Among women undergoing fertility treatment in the Netherlands between 1980 and 1995, the use of in vitro fertilization (IVF) compared with non-IVF treatment was not associated with increased risk of breast cancer after a ...

Mortality up with depression just before breast cancer diagnosis

April 14, 2017
(HealthDay)—Women with newly-developed depression before a breast cancer diagnosis have a modestly, but significantly, increased risk for death, according to a study published online April 7 in Cancer.

Early first cancer in BRCA1/2 ups risk in opposite breast

December 30, 2015
(HealthDay)—BRCA1/2 mutation carriers have increased risk of contralateral breast cancer (CBC), with age at first diagnosis a significant predictor of CBC risk, according to a study published online Dec. 23 in the Journal ...

Breast cancer patients with dense breast tissue more likely to develop contralateral disease

February 7, 2017
Breast cancer patients with dense breast tissue have almost a two-fold increased risk of developing disease in the contralateral breast, according to new research from The University of Texas MD Anderson Cancer.

Recommended for you

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

Brain powered: Increased physical activity among breast cancer survivors boosts cognition

September 19, 2017
It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help. In ...

Researchers compose guidelines for handling CAR T cell side effects

September 19, 2017
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects that provide a new challenge for oncologists, one addressed by a team led by clinicians at The University ...

Bone marrow protein a 'magnet' for passing prostate cancer cells

September 19, 2017
Scientists at the University of York have shown that a protein in the bone marrow acts like a 'magnetic docking station' for prostate cancer cells, helping them grow and spread outside of the prostate.

Brain cancer breakthrough could provide better treatment

September 19, 2017
A new discovery about the most common type of childhood brain cancer could transform treatment for young patients by enabling doctors to give the most effective therapies.

A new paradigm for treating transcription factor-driven cancers

September 18, 2017
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children's Hospital describe a new paradigm for treating transcription factor-driven cancers. The study focuses on Ewing ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.